Opportunity Information: Apply for PA 17 243
The NIH grant opportunity "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)" (Funding Opportunity Number PA 17 243) supports short, exploratory research projects that use data that already exist rather than generating entirely new datasets. The central purpose is to accelerate progress in cancer epidemiology by funding teams that can reanalyze, combine, and integrate existing genetic or genomic datasets (and related database resources) to better understand how inherited genetic variation contributes to cancer risk and cancer-related outcomes. In practical terms, the FOA is aimed at extracting new scientific value from data that have already been collected, often at substantial prior cost, by applying innovative analytic strategies, asking new questions of old datasets, or merging multiple resources in ways that were not previously feasible.
A key theme of the announcement is data integration across domains. While the emphasis is on genetic and genomic information, applicants are explicitly encouraged to pair those data with other types of existing information such as environmental exposures, clinical outcomes, behavioral factors, lifestyle variables, and molecular profiling data. This reflects how cancer risk and progression are shaped by complex interactions, and it signals that proposals are welcome when they connect genetic architecture to real-world outcomes and contexts rather than treating genetics in isolation. The expectation is that projects will use creative secondary analyses to address important questions, for example by refining risk estimates, identifying genetic contributors across populations, exploring gene-environment interplay, improving understanding of cancer susceptibility or prognosis, or clarifying how genetic factors relate to intermediate phenotypes and downstream cancer-related endpoints.
The FOA is positioned to support research that is methodologically forward-looking as well as substantively impactful. It encourages applications that (1) introduce new research aims that can be answered using data already in hand, (2) apply new or advanced analytical methods to existing genetic or genomic data, and/or (3) assemble novel combinations of datasets to enable questions that could not be addressed within a single study. In other words, the competitive edge is expected to come from what the investigators can do with existing resources: better study design at the analysis stage, improved statistical genetics or computational approaches, thoughtful harmonization across datasets, and careful integration of diverse data types to illuminate cancer risk and related outcomes.
This is an R21 mechanism, which generally aligns with early-stage, exploratory, or proof-of-concept projects that can demonstrate feasibility and generate compelling findings or preliminary evidence for larger follow-on studies. The source information lists an award ceiling of $200,000. The funding instrument is a grant, categorized under health and education activities, and administered by the National Institutes of Health. The CFDA numbers associated with the opportunity are 93.121, 93.393, and 93.396, indicating alignment with NIH programs relevant to cancer and related biomedical research.
Eligibility is broad and includes many types of institutions and organizations, reflecting NIH's intent to encourage participation across sectors and communities. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with and without 501(c)(3) status (excluding institutions of higher education where specified); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) organizations. This breadth underscores an interest in enabling diverse teams to bring different datasets, perspectives, and population coverage to cancer genetic epidemiology.
Finally, the published record shows a creation date of 2017-03-30 and an original closing date of 2020-05-07, which is useful for historical context when assessing whether the specific announcement is currently active or whether a newer reissued FOA should be used. Conceptually, though, the scientific focus remains clear: projects should be driven by the reuse and integration of existing genetic/genomic and complementary data to answer meaningful questions about the genetic architecture of cancer risk and outcomes, using innovative analysis rather than new primary data collection.Apply for PA 17 243
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.393, 93.396.
- This funding opportunity was created on 2017-03-30.
- Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education, Health
Next opportunity: Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Evidence-Based Research Findings (R18)
Previous opportunity: FY 2017 International Sports Programming Initiative
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 17 243
Applicants also applied for:
Applicants who have applied for this opportunity (PA 17 243) also looked into and applied for these:
| Funding Opportunity |
|---|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Apply for PA 17 239 Funding Number: PA 17 239 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp) Apply for PA 17 248 Funding Number: PA 17 248 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Apply for PAR 17 244 Funding Number: PAR 17 244 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Extracellular Vesicles and Substance Use Disorders (R21) Apply for PAR 17 242 Funding Number: PAR 17 242 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Apply for PAR 17 245 Funding Number: PAR 17 245 Agency: National Institutes of Health Category: Education, Health Funding Amount: $450,000 |
| Extracellular Vesicles and Substance Use Disorders (R01) Apply for PAR 17 250 Funding Number: PAR 17 250 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Expanding Medication Assisted Treatment for Opioid Use Disorders in the Context of the SAMHSA Opioid STR Grants (R21/R33) Apply for RFA DA 18 005 Funding Number: RFA DA 18 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Nasal Delivery of CNS Therapeutics (R43/R44) Apply for RFA DA 18 006 Funding Number: RFA DA 18 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Nasal Delivery of CNS Therapeutics (R41/R42) Apply for RFA DA 18 007 Funding Number: RFA DA 18 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01) Apply for RFA MH 18 300 Funding Number: RFA MH 18 300 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21) Apply for RFA MH 18 301 Funding Number: RFA MH 18 301 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Genomic Community Resources (U24) Apply for PAR 17 273 Funding Number: PAR 17 273 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) Apply for PA 17 280 Funding Number: PA 17 280 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01) Apply for PA 17 279 Funding Number: PA 17 279 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44) Apply for RFA DA 18 010 Funding Number: RFA DA 18 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01) Apply for RFA DA 18 008 Funding Number: RFA DA 18 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21) Apply for RFA DA 18 009 Funding Number: RFA DA 18 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21) Apply for PA 17 281 Funding Number: PA 17 281 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21) Apply for PA 17 278 Funding Number: PA 17 278 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Apply for PA 17 289 Funding Number: PA 17 289 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 17 243", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.